Hydrocortisone improved dexamethasone-induced neuropsychological adverse effects

Momoko Oyake¹, Tomoyo Itonaga¹, Naoki Hirano¹, Souichi Suenobu^{1

2}, Kenji Ihara¹

Affiliations

¹ Department of Pediatrics, Oita University Faculty of Medicine, Yufu, Oita, Japan.
² Division of General Pediatrics and Emergency Medicine, Oita University Faculty of Medicine, Yufu, Oita, Japan.

Momoko Oyake et al. Pediatr Int. 2021 Mar.

. 2021 Mar;63(3):339-342.

doi: 10.1111/ped.14413. Epub 2021 Feb 13.

Momoko Oyake¹, Tomoyo Itonaga¹, Naoki Hirano¹, Souichi Suenobu^{1

2}, Kenji Ihara¹

¹ Department of Pediatrics, Oita University Faculty of Medicine, Yufu, Oita, Japan.
² Division of General Pediatrics and Emergency Medicine, Oita University Faculty of Medicine, Yufu, Oita, Japan.

No abstract available

Keywords: dexamethasone; hydrocortisone; mineralocorticoid receptor; steroid-induced neuropsychological adverse effects.

References

1. Warris LT, van den Heuvel-Eibrink MM, Aarsen FK et al. Hydrocortisone as an intervention for dexamethasone-induced adverse effects in pediatric patients with acute lymphoblastic leukemia: Results of a double-blind. Randomized Controlled Trial. J. Clin. Oncol. 2016; 34: 2287-93.
1. Hoshino H, Matsuishi Y, Shimojo N et al. Development of the Japanese version of the cornell assessment of pediatric delirium. Acute Med. Surg. 2018; 5: 98-101.
1. Warris LT, van den Akker EL, Aarsen FK et al. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia. Psychoneuroendocrinology. 2016; 72: 190-5.
1. Lin AN, Paget SA. Principles of Corticosteroid Therapy. Arnold; Distributed in the USA by Oxford University Press, London; New York, NY, 2002.
1. Meijer OC, de Kloet ER. A refill for the brain mineralocorticoid receptor: The benefit of cortisol add-on to dexamethasone therapy. Endocrinology 2017; 158: 448-54.